Synonyms: Nucala® | SB-240563
mepolizumab is an approved drug (EMA & FDA (2015))
Compound class:
Antibody
Comment: The Nucala® brand of mepolizumab is a humanized interleukin-5 antagonist monoclonal antibody produced by recombinant DNA technology in Chinese hamster ovary cells.
View more information in the IUPHAR Pharmacology Education Project: mepolizumab |
Classification | |
Compound class | Antibody |
Approved drug? | Yes (EMA & FDA (2015)) |
International Nonproprietary Names | |
INN number | INN |
7876 | mepolizumab |
Synonyms |
Nucala® | SB-240563 |
Database Links | |
Specialist databases | |
IMGT/mAb-DB | 87 |
Other databases | |
GtoPdb PubChem SID | 223366020 |
Search PubMed clinical trials | mepolizumab |
Search PubMed titles | mepolizumab |
Search PubMed titles/abstracts | mepolizumab |
Wikipedia | Mepolizumab |